Post-Marketing Pharmacovigilance And Medical Information Global Market Report 2025

Description

Post-marketing pharmacovigilance refers to the ongoing surveillance of a drug's safety after it has been released to the market, with the aim of detecting, assessing, and preventing adverse effects or other drug-related problems. Medical information services complement this by providing accurate, scientific, and up-to-date information to healthcare professionals and patients regarding a drug's use, safety, and effectiveness. Together, these practices protect patient health, ensure regulatory compliance, and improve overall treatment outcomes.

The main types of post-marketing pharmacovigilance and medical information include spontaneous reporting, intensified adverse drug reaction (ADR) reporting, targeted spontaneous reporting, cohort event monitoring, and electronic health record (EHR) mining. Spontaneous reporting refers to healthcare professionals or patients voluntarily observing and reporting unexpected reactions linked to medication use to authorized regulatory bodies. The information is disseminated through various product types, such as books, online media, and journals, and serves a wide range of end users, including hospitals, research organizations, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The post-marketing pharmacovigilance and medical information market research report is one of a series of new reports from The Business Research Company that provides post-marketing pharmacovigilance and medical information market statistics, including post-marketing pharmacovigilance and medical information industry global market size, regional shares, competitors with a post-marketing pharmacovigilance and medical information market share, detailed post-marketing pharmacovigilance and medical information market segments, market trends and opportunities, and any further data you may need to thrive in the post-marketing pharmacovigilance and medical information industry. This post-marketing pharmacovigilance and medical information market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The post-marketing pharmacovigilance and medical information market size has grown rapidly in recent years. It will grow from $6.16 billion in 2024 to $6.90 billion in 2025 at a compound annual growth rate (CAGR) of 11.9%. The growth during the historic period can be attributed to the increasing integration of AI in pharmacovigilance processes, rising demand for outsourced drug safety services, the growing complexity of biopharmaceutical products, a stronger focus on patient-reported outcomes, and enhanced collaboration between regulatory agencies and the pharmaceutical industry.

The post-marketing pharmacovigilance and medical information market size is expected to see rapid growth in the next few years. It will grow to $10.68 billion in 2029 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to advancements in drug safety analytics tools, the rising adoption of cloud-based pharmacovigilance solutions, an increasing number of novel therapeutic launches, a stronger emphasis on proactive risk management strategies, and expanding pharmacovigilance requirements in emerging markets. Key trends expected during this period include progress in automated adverse event detection, the development of integrated pharmacovigilance platforms, innovations in real-time safety data monitoring, advancements in patient engagement tools for safety reporting, and the use of predictive analytics for drug risk assessment.

The increasing occurrence of adverse drug reactions is expected to drive the growth of the post-marketing pharmacovigilance and medical information market in the coming years. Adverse drug reactions are harmful or unintended effects that occur when a medication is taken at its recommended dosage for prevention, diagnosis, or treatment. Their incidence is rising as the aging population requires treatment for multiple chronic conditions, leading to the use of several medications at once, which raises the risk of harmful drug interactions and unexpected side effects. Post-marketing pharmacovigilance and medical information help manage these reactions by identifying, tracking, and sharing details on potential side effects after a drug is launched, thereby ensuring its safety and effectiveness. For example, in January 2023, according to Navikenz, a US-based artificial intelligence-focused IT services company, adverse drug reactions in the US are estimated to cause between 200,000 and 400,000 deaths annually, surpassing the toll from stroke and diabetes combined. Additionally, there are approximately 2.7 million cases each year, leading to over 100,000 hospitalizations and more than 15,000 deaths. As a result, the increasing incidence of adverse drug reactions is boosting the growth of the post-marketing pharmacovigilance and medical information market.

Leading companies in the post-marketing pharmacovigilance and medical information market are developing advanced solutions, such as AI-powered pharmacovigilance workflows, to improve the accuracy of adverse event detection and enable real-time safety monitoring for better patient outcomes. These workflows leverage artificial intelligence to automate drug safety monitoring, allowing quicker detection of adverse events and ensuring regulatory compliance. For instance, in January 2024, PubHive Ltd., a UK-based cloud-based software-as-a-service (SaaS) company, launched a centralized Summary of Product Characteristics (SmPC) management system for life science companies and research organizations. This platform consolidates essential drug safety data into a single accessible repository, automates literature monitoring and regulatory reporting, enhances team collaboration, and streamlines compliance processes through advanced AI capabilities. As a result, pharmacovigilance teams can work more efficiently and proactively, safeguarding patient safety while meeting regulatory standards.

In October 2023, Ergomed plc, a UK-based pharmaceutical services company, acquired Panacea Pharma Projects Limited for an undisclosed sum. Through this acquisition, Ergomed aims to expand its pharmacovigilance division, PrimeVigilance, strengthen its service capabilities, and broaden its global presence, supporting its strategy to become a leading provider of pharmacovigilance solutions. Panacea Pharma Projects Limited is a UK-based pharmaceutical consultancy specializing in pharmacovigilance and medical information services, including post-marketing support.

Major players in the post-marketing pharmacovigilance and medical information market are Cencora Inc., Cardinal Health Inc., Accenture plc, Sanofi S.A., Thermo Fisher Scientific Inc., Capgemini SE, Merck & Co. Inc., Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., HCL Technologies Limited, Laboratory Corporation of America Holdings, ICON plc, WuXi AppTec Co. Ltd., Syneos Health Inc., Genpact Limited, Charles River Laboratories International Inc., Parexel International Corporation, Avalere Health LLC, Quanticate Limited, Inizio Consulting LLC.

North America was the largest region in the post-marketing pharmacovigilance and medical information market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in post-marketing pharmacovigilance and medical information market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the post-marketing pharmacovigilance and medical information market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The post-marketing pharmacovigilance and medical information market includes revenues earned by entities by providing services such as adverse event reporting and management, signal detection and risk assessment, drug safety database, medical call center services, and regulatory compliance support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Post-Marketing Pharmacovigilance And Medical Information Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on post-marketing pharmacovigilance and medical information market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for post-marketing pharmacovigilance and medical information ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The post-marketing pharmacovigilance and medical information market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Spontaneous Reporting; Intensified Adverse Drug Reaction (ADR) Reporting; Targeted Spontaneous Reporting; Cohort Event Monitoring; Electronic Health Record (EHR) Mining
2) By Product: Books; Online Media; Journals
3) By End User: Hospitals; Research Organizations; Other End-Users
Subsegments:
1) By Spontaneous Reporting: Consumer Reporting; Healthcare Professional Reporting; Regulatory Authority Reporting; Pharmaceutical Company Reporting; Digital App-Based Reporting
2) By Intensified Adverse Drug Reaction (ADR) Reporting: Hospital-Based Surveillance; Program-Specific Monitoring; Disease-Specific Monitoring; Product-Specific Monitoring; Real-Time Monitoring Systems
3) By Targeted Spontaneous Reporting: Risk Population-Based Reporting; Therapeutic Class-Based Reporting; Adverse Drug Reaction Focused Reporting; Region-Specific Reporting; Healthcare Setting-Specific Reporting
4) By Cohort Event Monitoring: Prospective Cohort Monitoring; Retrospective Cohort Monitoring; Active Follow-Up Monitoring; New Drug User Monitoring; Disease Registry-Linked Monitoring
5) By Electronic Health Record (EHR) Mining: Natural Language Processing-Based Mining; Artificial Intelligence (AI) And Machine Learning Algorithms; Rule-Based Signal Detection; Longitudinal Patient Data Analysis; Integrated Hospital Data Systems
Companies Mentioned: Cencora Inc.; Cardinal Health Inc.; Accenture plc; Sanofi S.A.; Thermo Fisher Scientific Inc.; Capgemini SE; Merck & Co. Inc.; Cognizant Technology Solutions Corporation; IQVIA Holdings Inc.; HCL Technologies Limited; Laboratory Corporation of America Holdings; ICON plc; WuXi AppTec Co. Ltd.; Syneos Health Inc.; Genpact Limited; Charles River Laboratories International Inc.; Parexel International Corporation; Avalere Health LLC; Quanticate Limited; Inizio Consulting LLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r37864

1. Executive Summary

2. Post-Marketing Pharmacovigilance And Medical Information Market Characteristics

3. Post-Marketing Pharmacovigilance And Medical Information Market Trends And Strategies

4. Post-Marketing Pharmacovigilance And Medical Information Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Post-Marketing Pharmacovigilance And Medical Information Growth Analysis And Strategic Analysis Framework

5.1. Global Post-Marketing Pharmacovigilance And Medical Information PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Post-Marketing Pharmacovigilance And Medical Information Market Growth Rate Analysis
5.4. Global Post-Marketing Pharmacovigilance And Medical Information Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Post-Marketing Pharmacovigilance And Medical Information Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Post-Marketing Pharmacovigilance And Medical Information Total Addressable Market (TAM)

6. Post-Marketing Pharmacovigilance And Medical Information Market Segmentation

6.1. Global Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Spontaneous Reporting
Intensified Adverse Drug Reaction (ADR) Reporting
Targeted Spontaneous Reporting
Cohort Event Monitoring
Electronic Health Record (EHR) Mining
6.2. Global Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Books
Online Media
Journals
6.3. Global Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Research Organizations
Other End-Users
6.4. Global Post-Marketing Pharmacovigilance And Medical Information Market, Sub-Segmentation Of Spontaneous Reporting, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Consumer Reporting
Healthcare Professional Reporting
Regulatory Authority Reporting
Pharmaceutical Company Reporting
Digital App-Based Reporting
6.5. Global Post-Marketing Pharmacovigilance And Medical Information Market, Sub-Segmentation Of Intensified Adverse Drug Reaction (ADR) Reporting, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital-Based Surveillance
Program-Specific Monitoring
Disease-Specific Monitoring
Product-Specific Monitoring
Real-Time Monitoring Systems
6.6. Global Post-Marketing Pharmacovigilance And Medical Information Market, Sub-Segmentation Of Targeted Spontaneous Reporting, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Risk Population-Based Reporting
Therapeutic Class-Based Reporting
Adverse Drug Reaction Focused Reporting
Region-Specific Reporting
Healthcare Setting-Specific Reporting
6.7. Global Post-Marketing Pharmacovigilance And Medical Information Market, Sub-Segmentation Of Cohort Event Monitoring, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prospective Cohort Monitoring
Retrospective Cohort Monitoring
Active Follow-Up Monitoring
New Drug User Monitoring
Disease Registry-Linked Monitoring
6.8. Global Post-Marketing Pharmacovigilance And Medical Information Market, Sub-Segmentation Of Electronic Health Record (EHR) Mining, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Natural Language Processing-Based Mining
Artificial Intelligence (AI) And Machine Learning Algorithms
Rule-Based Signal Detection
Longitudinal Patient Data Analysis
Integrated Hospital Data Systems

7. Post-Marketing Pharmacovigilance And Medical Information Market Regional And Country Analysis

7.1. Global Post-Marketing Pharmacovigilance And Medical Information Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Post-Marketing Pharmacovigilance And Medical Information Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Post-Marketing Pharmacovigilance And Medical Information Market

8.1. Asia-Pacific Post-Marketing Pharmacovigilance And Medical Information Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Post-Marketing Pharmacovigilance And Medical Information Market

9.1. China Post-Marketing Pharmacovigilance And Medical Information Market Overview
9.2. China Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Post-Marketing Pharmacovigilance And Medical Information Market

10.1. India Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Post-Marketing Pharmacovigilance And Medical Information Market

11.1. Japan Post-Marketing Pharmacovigilance And Medical Information Market Overview
11.2. Japan Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Post-Marketing Pharmacovigilance And Medical Information Market

12.1. Australia Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Post-Marketing Pharmacovigilance And Medical Information Market

13.1. Indonesia Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Post-Marketing Pharmacovigilance And Medical Information Market

14.1. South Korea Post-Marketing Pharmacovigilance And Medical Information Market Overview
14.2. South Korea Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Post-Marketing Pharmacovigilance And Medical Information Market

15.1. Western Europe Post-Marketing Pharmacovigilance And Medical Information Market Overview
15.2. Western Europe Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Post-Marketing Pharmacovigilance And Medical Information Market

16.1. UK Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Post-Marketing Pharmacovigilance And Medical Information Market

17.1. Germany Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Post-Marketing Pharmacovigilance And Medical Information Market

18.1. France Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Post-Marketing Pharmacovigilance And Medical Information Market

19.1. Italy Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Post-Marketing Pharmacovigilance And Medical Information Market

20.1. Spain Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Post-Marketing Pharmacovigilance And Medical Information Market

21.1. Eastern Europe Post-Marketing Pharmacovigilance And Medical Information Market Overview
21.2. Eastern Europe Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Post-Marketing Pharmacovigilance And Medical Information Market

22.1. Russia Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Post-Marketing Pharmacovigilance And Medical Information Market

23.1. North America Post-Marketing Pharmacovigilance And Medical Information Market Overview
23.2. North America Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Post-Marketing Pharmacovigilance And Medical Information Market

24.1. USA Post-Marketing Pharmacovigilance And Medical Information Market Overview
24.2. USA Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Post-Marketing Pharmacovigilance And Medical Information Market

25.1. Canada Post-Marketing Pharmacovigilance And Medical Information Market Overview
25.2. Canada Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Post-Marketing Pharmacovigilance And Medical Information Market

26.1. South America Post-Marketing Pharmacovigilance And Medical Information Market Overview
26.2. South America Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Post-Marketing Pharmacovigilance And Medical Information Market

27.1. Brazil Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Post-Marketing Pharmacovigilance And Medical Information Market

28.1. Middle East Post-Marketing Pharmacovigilance And Medical Information Market Overview
28.2. Middle East Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Post-Marketing Pharmacovigilance And Medical Information Market

29.1. Africa Post-Marketing Pharmacovigilance And Medical Information Market Overview
29.2. Africa Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Post-Marketing Pharmacovigilance And Medical Information Market Competitive Landscape And Company Profiles

30.1. Post-Marketing Pharmacovigilance And Medical Information Market Competitive Landscape
30.2. Post-Marketing Pharmacovigilance And Medical Information Market Company Profiles
- 30.2.1. Cencora Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Accenture plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Post-Marketing Pharmacovigilance And Medical Information Market Other Major And Innovative Companies

31.1. Capgemini SE
31.2. Merck & Co. Inc.
31.3. Cognizant Technology Solutions Corporation
31.4. IQVIA Holdings Inc.
31.5. HCL Technologies Limited
31.6. Laboratory Corporation of America Holdings
31.7. ICON plc
31.8. WuXi AppTec Co. Ltd.
31.9. Syneos Health Inc.
31.10. Genpact Limited
31.11. Charles River Laboratories International Inc.
31.12. Parexel International Corporation
31.13. Avalere Health LLC
31.14. Quanticate Limited
31.15. Inizio Consulting LLC

32. Global Post-Marketing Pharmacovigilance And Medical Information Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Post-Marketing Pharmacovigilance And Medical Information Market

34. Recent Developments In The Post-Marketing Pharmacovigilance And Medical Information Market

35. Post-Marketing Pharmacovigilance And Medical Information Market High Potential Countries, Segments and Strategies

35.1 Post-Marketing Pharmacovigilance And Medical Information Market In 2029 - Countries Offering Most New Opportunities
35.2 Post-Marketing Pharmacovigilance And Medical Information Market In 2029 - Segments Offering Most New Opportunities
35.3 Post-Marketing Pharmacovigilance And Medical Information Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer